| Scott Alan Naegele, MD | |
|
830 Pennsylvania Ave, Suite 108, Charleston, WV 25302-3389 | |
| (304) 344-8368 | |
| (304) 342-8938 |
| Full Name | Scott Alan Naegele |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 34 Years |
| Location | 830 Pennsylvania Ave, Charleston, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447253497 | NPI | - | NPPES |
| 0092820000 | Medicaid | WV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 17050 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Charleston Area Medical Center | Charleston, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Womencare Inc | 4587568134 | 47 |
News Archive
Imagine a barking dog, a furry spider or another perceived threat and your brain and body respond much like they would if you experienced the real thing.
Researchers in Brazil have identified a correlation between oral cancer progression and the abundance of certain proteins present in tumor tissue and saliva.
The largest study ever conducted on acne and stress reveals that teenagers who were under high levels of stress were 23 percent more likely to have increased acne severity, according to researchers from Wake Forest University School of Medicine and colleagues.
BioMarin Pharmaceutical Inc. today announced financial results for the fourth quarter and year ended December 31, 2009. GAAP net income was $4.7 million ($0.05 per diluted share) for the fourth quarter of 2009, compared to GAAP net income of $24.5 million ($0.21 per diluted share) for the fourth quarter of 2008, which included a $30.0 million payment from Merck Serono related to the approval of Kuvan in the EU.
› Verified 1 days ago
| Entity Name | Davis Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619964806 PECOS PAC ID: 3072418540 Enrollment ID: O20040107000438 |
News Archive
Imagine a barking dog, a furry spider or another perceived threat and your brain and body respond much like they would if you experienced the real thing.
Researchers in Brazil have identified a correlation between oral cancer progression and the abundance of certain proteins present in tumor tissue and saliva.
The largest study ever conducted on acne and stress reveals that teenagers who were under high levels of stress were 23 percent more likely to have increased acne severity, according to researchers from Wake Forest University School of Medicine and colleagues.
BioMarin Pharmaceutical Inc. today announced financial results for the fourth quarter and year ended December 31, 2009. GAAP net income was $4.7 million ($0.05 per diluted share) for the fourth quarter of 2009, compared to GAAP net income of $24.5 million ($0.21 per diluted share) for the fourth quarter of 2008, which included a $30.0 million payment from Merck Serono related to the approval of Kuvan in the EU.
› Verified 1 days ago
| Entity Name | Reynolds Memorial Hospital, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518068014 PECOS PAC ID: 9830184530 Enrollment ID: O20040420000896 |
News Archive
Imagine a barking dog, a furry spider or another perceived threat and your brain and body respond much like they would if you experienced the real thing.
Researchers in Brazil have identified a correlation between oral cancer progression and the abundance of certain proteins present in tumor tissue and saliva.
The largest study ever conducted on acne and stress reveals that teenagers who were under high levels of stress were 23 percent more likely to have increased acne severity, according to researchers from Wake Forest University School of Medicine and colleagues.
BioMarin Pharmaceutical Inc. today announced financial results for the fourth quarter and year ended December 31, 2009. GAAP net income was $4.7 million ($0.05 per diluted share) for the fourth quarter of 2009, compared to GAAP net income of $24.5 million ($0.21 per diluted share) for the fourth quarter of 2008, which included a $30.0 million payment from Merck Serono related to the approval of Kuvan in the EU.
› Verified 1 days ago
| Entity Name | Womens Health Center Of West Virginia Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073679254 PECOS PAC ID: 1052445624 Enrollment ID: O20100818000359 |
News Archive
Imagine a barking dog, a furry spider or another perceived threat and your brain and body respond much like they would if you experienced the real thing.
Researchers in Brazil have identified a correlation between oral cancer progression and the abundance of certain proteins present in tumor tissue and saliva.
The largest study ever conducted on acne and stress reveals that teenagers who were under high levels of stress were 23 percent more likely to have increased acne severity, according to researchers from Wake Forest University School of Medicine and colleagues.
BioMarin Pharmaceutical Inc. today announced financial results for the fourth quarter and year ended December 31, 2009. GAAP net income was $4.7 million ($0.05 per diluted share) for the fourth quarter of 2009, compared to GAAP net income of $24.5 million ($0.21 per diluted share) for the fourth quarter of 2008, which included a $30.0 million payment from Merck Serono related to the approval of Kuvan in the EU.
› Verified 1 days ago
| Entity Name | Thomas Hunter & Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154734465 PECOS PAC ID: 8022331529 Enrollment ID: O20150107001899 |
News Archive
Imagine a barking dog, a furry spider or another perceived threat and your brain and body respond much like they would if you experienced the real thing.
Researchers in Brazil have identified a correlation between oral cancer progression and the abundance of certain proteins present in tumor tissue and saliva.
The largest study ever conducted on acne and stress reveals that teenagers who were under high levels of stress were 23 percent more likely to have increased acne severity, according to researchers from Wake Forest University School of Medicine and colleagues.
BioMarin Pharmaceutical Inc. today announced financial results for the fourth quarter and year ended December 31, 2009. GAAP net income was $4.7 million ($0.05 per diluted share) for the fourth quarter of 2009, compared to GAAP net income of $24.5 million ($0.21 per diluted share) for the fourth quarter of 2008, which included a $30.0 million payment from Merck Serono related to the approval of Kuvan in the EU.
› Verified 1 days ago
| Entity Name | Womencare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790276525 PECOS PAC ID: 4587568134 Enrollment ID: O20181102002547 |
News Archive
Imagine a barking dog, a furry spider or another perceived threat and your brain and body respond much like they would if you experienced the real thing.
Researchers in Brazil have identified a correlation between oral cancer progression and the abundance of certain proteins present in tumor tissue and saliva.
The largest study ever conducted on acne and stress reveals that teenagers who were under high levels of stress were 23 percent more likely to have increased acne severity, according to researchers from Wake Forest University School of Medicine and colleagues.
BioMarin Pharmaceutical Inc. today announced financial results for the fourth quarter and year ended December 31, 2009. GAAP net income was $4.7 million ($0.05 per diluted share) for the fourth quarter of 2009, compared to GAAP net income of $24.5 million ($0.21 per diluted share) for the fourth quarter of 2008, which included a $30.0 million payment from Merck Serono related to the approval of Kuvan in the EU.
› Verified 1 days ago
| Entity Name | Womencare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770745036 PECOS PAC ID: 4587568134 Enrollment ID: O20190806002319 |
News Archive
Imagine a barking dog, a furry spider or another perceived threat and your brain and body respond much like they would if you experienced the real thing.
Researchers in Brazil have identified a correlation between oral cancer progression and the abundance of certain proteins present in tumor tissue and saliva.
The largest study ever conducted on acne and stress reveals that teenagers who were under high levels of stress were 23 percent more likely to have increased acne severity, according to researchers from Wake Forest University School of Medicine and colleagues.
BioMarin Pharmaceutical Inc. today announced financial results for the fourth quarter and year ended December 31, 2009. GAAP net income was $4.7 million ($0.05 per diluted share) for the fourth quarter of 2009, compared to GAAP net income of $24.5 million ($0.21 per diluted share) for the fourth quarter of 2008, which included a $30.0 million payment from Merck Serono related to the approval of Kuvan in the EU.
› Verified 1 days ago
| Entity Name | Womencare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619679008 PECOS PAC ID: 4587568134 Enrollment ID: O20240118003427 |
News Archive
Imagine a barking dog, a furry spider or another perceived threat and your brain and body respond much like they would if you experienced the real thing.
Researchers in Brazil have identified a correlation between oral cancer progression and the abundance of certain proteins present in tumor tissue and saliva.
The largest study ever conducted on acne and stress reveals that teenagers who were under high levels of stress were 23 percent more likely to have increased acne severity, according to researchers from Wake Forest University School of Medicine and colleagues.
BioMarin Pharmaceutical Inc. today announced financial results for the fourth quarter and year ended December 31, 2009. GAAP net income was $4.7 million ($0.05 per diluted share) for the fourth quarter of 2009, compared to GAAP net income of $24.5 million ($0.21 per diluted share) for the fourth quarter of 2008, which included a $30.0 million payment from Merck Serono related to the approval of Kuvan in the EU.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Scott Alan Naegele, MD 830 Pennsylvania Ave, Ste 402, Charleston, WV 25302-3390 Ph: (304) 344-8368 | Scott Alan Naegele, MD 830 Pennsylvania Ave, Suite 108, Charleston, WV 25302-3389 Ph: (304) 344-8368 |
News Archive
Imagine a barking dog, a furry spider or another perceived threat and your brain and body respond much like they would if you experienced the real thing.
Researchers in Brazil have identified a correlation between oral cancer progression and the abundance of certain proteins present in tumor tissue and saliva.
The largest study ever conducted on acne and stress reveals that teenagers who were under high levels of stress were 23 percent more likely to have increased acne severity, according to researchers from Wake Forest University School of Medicine and colleagues.
BioMarin Pharmaceutical Inc. today announced financial results for the fourth quarter and year ended December 31, 2009. GAAP net income was $4.7 million ($0.05 per diluted share) for the fourth quarter of 2009, compared to GAAP net income of $24.5 million ($0.21 per diluted share) for the fourth quarter of 2008, which included a $30.0 million payment from Merck Serono related to the approval of Kuvan in the EU.
› Verified 1 days ago
Dr. Karinna Hope Andrews, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3110 Maccorkle Ave Se, Charleston, WV 25304 Phone: 304-388-2068 Fax: 304-388-2437 | |
Dr. Stephen Harold Bush, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 830 Pennsylvania Ave, Charleston, WV 25302 Phone: 304-388-1515 Fax: 304-388-1570 | |
Dr. Stephen Harold Bush Ii, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1 Courtney Dr, Charleston, WV 25304 Phone: 304-925-4200 Fax: 304-925-0483 | |
Ms. Lauren Nicole Becker, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 12 Courtney Dr, Charleston, WV 25304 Phone: 304-925-7600 | |
Jessica L Matheny, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 12 Courtney Dr, Charleston, WV 25304 Phone: 304-925-7600 Fax: 304-925-5892 | |
Mr. Robert Todd Depond, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 830 Pennsylvania Ave, Suite 304, Charleston, WV 25302 Phone: 304-388-1552 | |
Dr. David W Thomas, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 830 Pennsylvania Ave, Ste 402, Charleston, WV 25302 Phone: 304-343-5736 Fax: 304-343-5271 |